John Whiting

John L. Whiting, MD, FRACP, Infectious Disease and Internal Medicine physician in Brisbane, Australia, has concentrated his focus on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and related conditions since 1987. He is one of the researchers at Melbourne Bioanalytics, an Australian research group specializing in metabolomics, genomics and microbiomics research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Open letter to The Lancet

 * 19 June 2018, Dr Whiting signed an open letter to the editor of The Lancet urging the editor to commission a fully independent review of the PACE trial, which the journal published in 2011.

Notable studies

 * 1994, Illness behaviour of patients with chronic fatigue syndrome
 * 1995, Quality of life in chronic fatigue syndrome
 * 1998, Coincidental Splenectomy in Chronic Fatigue Syndrome

Clinic location
15 Morrow Street                                                                                                                                                                                                                                        Taringa,                                                                                Queensland, 4068, Australia

Talks and interviews

 * 2016, International Association for CFS/ME (IACFS/ME) conference, Florida, US

Online presence

 * Twitter
 * LinkedIn

Learn more

 * Melbourne Bioanalytics